Statin drug interactions and related adverse reactions.

@article{Bellosta2012StatinDI,
  title={Statin drug interactions and related adverse reactions.},
  author={Stefano Bellosta and Alberto Corsini},
  journal={Expert opinion on drug safety},
  year={2012},
  volume={11 6},
  pages={
          933-46
        }
}
INTRODUCTION Statin monotherapy is generally well tolerated, with a low frequency of adverse events. The most important adverse effects associated with statins are myopathy and an asymptomatic increase in hepatic transaminases, both of which occur infrequently. Because statins are prescribed on a long-term basis, their possible interactions with other drugs deserve particular attention, as many patients will typically receive pharmacological therapy for concomitant conditions during the course… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 36 CITATIONS

Toxicokinetics and toxicity of atorvastatin in dogs.

  • Toxicology and applied pharmacology
  • 2015
VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Prevalence of statin-drug interactions in older people: a systematic review

  • European Journal of Clinical Pharmacology
  • 2016
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Statin-Associated Side Effects.

  • Journal of the American College of Cardiology
  • 2016
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Supervised by Professor

VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin.

  • Expert opinion on drug metabolism & toxicology
  • 2014
VIEW 11 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 105 REFERENCES

Rosuvastatin-Associated Adverse Effects and Drug-Drug Interactions in the Clinical Setting of Dyslipidemia

  • American journal of cardiovascular drugs : drugs, devices, and other interventions
  • 2010
VIEW 12 EXCERPTS
HIGHLY INFLUENTIAL

Dyslipidemia and lipid management in HIV-infected patients.

  • Current opinion in endocrinology, diabetes, and obesity
  • 2011
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Drug-drug interaction with statins.

  • Expert review of clinical pharmacology
  • 2008
VIEW 7 EXCERPTS